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CASE REPORT
Plasmodium falciparum malaria 
co-infection with tick-borne relapsing fever 
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Abstract 
Background: West African tick-borne relapsing fever (TBRF) due to Borrelia crocidurae and malaria are co-endemics in 
Senegal. Although expected to be high, co-infections are rarely reported. A case of falciparum malaria and B. crocidu-
rae co-infection in a patient from Velingara (South of Senegal) is discussed.
Case: A 28 year-old-male patient presented to Aristide Le Dantec Hospital for recurrent fever. He initially presented to 
a local post health of Pikine (sub-urban of Dakar) and was diagnosed for malaria on the basis of positive malaria rapid 
diagnostic test (RDT) specific to Plamodium falciparum. The patient was treated as uncomplicated falciparum malaria. 
Four days after admission the patient was referred to Le Dantec Hospital. He presented with fever (39 °C), soreness, 
headache and vomiting. The blood pressure was 120/80 mmHg. The rest of the examination was normal. A thick film 
from peripheral blood was performed and addressed to the parasitology laboratory of the hospital. Thick film was 
stained with 10% Giemsa. Trophozoite of P. falciparum was identified at parasite density of 47 parasites per microlitre. 
The presence of Borrelia was also observed, concluding to malaria co-infection with borreliosis.
Conclusions: Signs of malaria can overlap with signs of borreliosis leading to the misdiagnosis of the latter. Thick and 
thin smear or QBC test or molecular method may be helpful to detect both Plamodium species and Borrelia. In addi-
tion, there is a real need to consider co-infections with other endemics pathogens when diagnosing malaria.
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Background
In Senegal, several areas are endemic for tick-borne 
relapsing fever (TBRF) and the causal agent is Borrelia 
crocidurae, which is transmitted by the tick, Ornitho-
dorus sonrai [1, 2]. The geographic distribution of TBRF 
is linked to drier climates [2, 3]. However, in Senegal, 
important extension towards the south due to climate 
change was observed [1, 3], and both malaria and tick-
borne relapsing fever (TBRF) due to B. crocidurae are 
endemic [4]. When there is no clinical evidence of other 
disease, falciparum malaria is the first suspected cause 
of fever in Senegal. However, borreliosis is also a major 
cause of fever in Senegal [5, 6]. Thus, co-infections of 
malaria-borreliosis are expected to be high but are rarely 
reported. A patient diagnosed for malaria and TBRF is 
discussed.
Case presentation
A 28-year-old-male patient presented on June 9, 2016 to 
the health post of Pikine (sub-urban of Dakar) for head-
ache, vomiting, diarrhea, low back pain and arthralgia. 
Suspecting malaria, an HRP2-based RDT specific to Plas-
modium falciparum was performed. The test was positive 
for falciparum malaria. Following the Senegalese national 
policy guidelines for the treatment for uncomplicated 
malaria, the patient was given artemether 20 mg + lume-
fantrine 120  mg at admission and every 8  h for a total 
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of six doses. Four days later, the patient was referred to 
Aristide Le Dantec Hospital. He presented with fever 
(39 °C), soreness, abdominal pain and vomiting.
The onset of symptoms had occurred brutally 4  days 
before, marked by intense and not radiating back pain 
without triggers or calming factors. There was also con-
tinuous soreness and joint pain without any particular 
pattern, associating intense asthenia, which is temporar-
ily relieved by usual analgesics. There was also diffuse 
headache, without axial stiffness. There was no photo-
phobia nor phonophobia, associating with vomiting and 
nausea, two to three fluids diarrhoeas that lasted 3 days 
without fever nor concept of eating suspected food and 
no similar cases in the entourage.
Investigations shown that the patient was from Velin-
gara (south of Senegal) and had come to Dakar 2 months 
earlier. He had no previous medical history. The blood 
pressure was 120/80 mmHg. There was no sign of clini-
cal anaemia. The rest of the examination was normal. 
Laboratory test showed thrombocytopenia (platelets 
40 × 109/mm3) as the only abnormal haematological test. 
A thick film from peripheral blood was performed and 
sent to the parasitology laboratory of Le Dantec Hospi-
tal. Thick film was stained with 10% Giemsa. Trophozoite 
of P. falciparum was identified at parasite density of 47 
parasites per microlitre. In addition, spirochetes of Borre-
lia were observed indicating a malaria co-infection with 
borreliosis (Fig. 1).
Treatment consisted of doxycycline 200 mg daily dur-
ing 14 days. No further symptoms were noted. Effective-
ness of treatment was confirmed by negative microscopy 
for both malaria parasites and spirochetes.
Discussion
Malaria co-infection with borreliosis, rarely reported, 
poses diagnostic challenge [4, 7, 8].
Tropical borreliosis is often disregarded [9] and is often 
confused with malaria, which affects the same people and 
presents with similar symptoms [5]. The disease called 
relapsing fever was considered rare until the late 1980s, 
before it was demonstrated that in many rural areas of 
Senegal, tick-borne borreliosis was the second cause 
of febrile diagnosis (after malaria) [1]. With an average 
annual incidence of 11% for over 14 years, this is the high-
est rate measured in Africa for a bacterial disease [10].
Borreliosis is a major public health problem in most 
rural areas of Senegal. However, although it is the most 
common bacterial disease, it remains relatively unknown 
by the healthcare personnel. Most likely, misdiagnosed 
co-infections are believed to be malaria resistant to anti-
malarial drugs [5]. Also, malaria is often diagnosed on 
the basis of only clinical symptoms and positive RDT, not 
microscopic examination of thick and thin smear, which 
increases misdiagnosis of possible co-infections. In addi-
tion, B. crocidurae is present in the blood in small quan-
tities. It is detectable in the blood samples by a trained 
microscopist and only during peaks of fever [6]. In the co-
infection Borrelia-Plasmodium, when examining thin or 
thick smears, high density Plasmodium may obscure the 
presence of the spirochetes, making it difficult to detect 
the co-infecting bacteria [4]. In this case, conversely, low 
parasite density of P. falciparum was observed probably 
due to parasite clearance after effective treatment just 
after the patient was diagnosed by malaria RDT.
Routinely, the diagnosis of both tick-borne relaps-
ing fever and malaria is based on the detection of the 
pathogen in the patient’s peripheral blood. Borrelia and 
malaria parasites can be observed in Giemsa-stained 
thick/thin smears or fluorescence microscopy after 
Fig. 1 Giemsa-stained thick blood smears showing trophozoite of P. 
falciparum (black arrow) and spirochetes of Borrelia (red arrow)
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centrifugation of blood in capillary tubes and stain-
ing with acridine orange (quantitative buffy coat [QBC] 
analysis) [3]. Borrelia can also be observed in dark field 
or phase contrast microscopy [3]. Positivity thresholds of 
thin and thick smear blood are respectively estimated at 
105 and 104 spirochetes per milliliter of blood [4]. Giemsa 
method has sensitivity estimated at 25% of the reference 
technique (the intraperitoneal inoculation of mice is the 
gold standard in the diagnosis of TBRF) [6, 11]. Long and 
careful examination of a thick smear made at a feverish 
peak achieves the sensitivity from 50 to 70%.
Quantitative Buffy Coat (QBC test) is a technique for 
rapid detection of malaria parasites with good sensitiv-
ity and specificity. Also the QBC is very useful in Borre-
lia detection, allowing the technician to examine a larger 
volume of blood. With a positivity threshold of 103 spi-
rochetes/ml, this technique is 100 times more sensitive 
than the blood smear in the diagnosis of borreliosis [4].
Velingara is out of the distribution area of tick-borne 
borreliosis in Senegal [2]. Thus, the patient described 
here was most probably infected in Pikine (Dakar), where 
malaria is endemic and where O. sonrai is abundant 
in burrows of mice and rats [2]. Transmission of bor-
reliosis is well known to occur in all regions of Senegal 
north of the Gambian border [2, 5], explaining the high 
probability for people to be co-infected by Plasmodium 
and spirochetes. Moreover, the patient stayed in Dakar 
for 2 months that largely exceeds the incubation period 
(4–14 days) for relapsing fevers [12].
Since RDTs are provided to all health clinics in Sene-
gal, any positive test is systematically treated as malaria 
without considering possible co-infections. Incorrect 
treatment may result in persisting symptoms leading the 
physician to wrongly conclude drug resistant malaria. 
Prompt diagnosis of TBRF and appropriate treatment 
would avoid developing complications such as severe 
meningoencephalitis [3]. The recommended treatment 
for borreliosis is doxycycline 100 mg twice daily or eryth-
romycin 500 mg every 6 h per os [7].
Conclusions
This case illustrates the importance of effective and accu-
rate diagnostic testing in tropical area where co-infec-
tions are expected to be high. TBRF should be considered 
in the diagnosis of every febrile patient returning from 
endemic areas even when malaria RDT is positive. Diag-
nosis relies upon routinely microscopic examination of 
thick and thin smear. QBC might increase the sensitivity 
and when available, molecular tools are highly effective in 
detecting spirochetes.
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